Pronounced: TER ige e em
A pterygium is an abnormal, noncancerous growth of the conjunctiva. The conjunctiva is a thin membrane lining the inside of the eyelid and part of the eyeball. It is located between the sclera, or the "white of the eye" which surrounds the eyeball, and the cornea, the dome-shaped window covering the front of the eye which is responsible for the refraction of light. If a pterygium continues to grow, it may spread onto the cornea.
Copyright © Nucleus Medical Media, Inc.
Excessive growth of the conjunctiva leads to a pterygium. The exact cause of pterygium is unknown.
A risk factor is something that increases the chances of developing a disease or a condition.
Risk factors for pterygium include:
The symptoms of pterygia vary from person-to-person. It appears as a fleshy spot—whitish in color and containing blood vessels—extending onto the surface of the eye. In some people, pterygia remain small and do not affect vision. These pterygia are noticed only because of their abnormal cosmetic appearance. In other people, pterygia grow quickly and large enough to eventually distort the corneal surface and cause severely blurred vision. Pterygia do not cause pain.
Symptoms may include:
If you experience any of these symptoms do not assume it is due to pterygium. These symptoms may be caused by other eye conditions. If you experience any one of them, see your eye doctor.
Your eye doctor will ask about symptoms and medical history, and perform a complete eye examination. Tests may include the following:
The main goals of treating a pterygium are to:
Treatment options include:
If vision becomes severely blurred, the pterygium may need to be surgically removed. This is commonly done on an outpatient basis. On occasion, a pterygium can return. Steps may be taken during the operation to prevent this from happening.
In rare cases, a pterygium causes serious scarring of the cornea. If this happens, a corneal transplant may be needed. Once the pterygium has been surgically removed, the medicine Mitomycin C may be used to aid in healing and prevent recurrence.
American Academy of Ophthalmology
Eye Care America
Canadian Ophthalmological Society
Coday M. Pterygium. Digital Journal of Ophthalmology website. Available at: http://www.djo.harvard.edu/site.php?url=/patients/pi/426 . Accessed July 21, 2009.
Jurgenliemk-Schulz IM, Hartman LJ, Roesink JM, et al. Prevention of pterygium recurrence by postoperative single-dose beta-irradiation: a prostpective randomized clinical double-blind trial. Int J Radiat Oncol Biol Phys .2004; 59:1138-1147.
Kellogg Eye Institute. Pterygium. Kellogg Eye Institute, University of Michigan website. Available at: http://kellogg.umich.edu/patientcare/conditions/pterygium.html . Accessed August 12, 2005.
Sowka JW, Gurwood AS, Kabat AG. Handbook of Ocular Dsease Management. New York, NY: Jobson Publishing Co; 2001.
Washington University Physicians. Pterygium. Washington University Physicians website. Available at: http://wuphysicians.wustl.edu/page.aspx?pageID=516 . Accessed November 11, 2010.
Last reviewed June 2013 by Michael Woods, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2012 EBSCO Publishing All rights reserved.
What can we help you find?close ×